The new report by Expert Market Research titled, ‘Global Autogenous Vaccine Market Growth, Report and Forecast 2023-2028’, gives an in-depth analysis of the global autogenous vaccine market, assessing the market based on its segments like strain types, end uses, and major regions. The report tracks the latest trends in the industry and studies their impact on the overall market. It also assesses the market dynamics, covering the key demand and price indicators, along with analysing the market based on the SWOT and Porter’s Five Forces models.
The key highlights of the report include:
Market Overview (2018-2028)
- Forecast CAGR (2023-2028): 4.3%
The rising prevalence of contagious disease and a strong demand for customised vaccines is the key driving factor for the growth of the autogenous vaccines market. Additionally, the susceptibility of animals to contagious diseases such as pink eyes and peste des petitis ruminants (PPR) has created an increased demand for autogenous vaccines, which has further pushed the growth of The government and private contributions to minimise economic loss caused due to disruption of livestock by such contagious outbreaks are expected to provide with great opportunities for the growth. The development of veterinary science and increased research and development in the biotechnology field are also contributing factors for the growth of the market.
Industry Definition and Major Segments
Autogenous vaccine, also known as autologous vaccine, are custom vaccine, are developed from microbial cultures obtained from individual, then subsequently used to provide immunity to the same individual.
By strain type, the market is segmented into:
- Bacterial Strain
- Virus Strain
On the basis of end use, the industry is divided into:
- Veterinary Clinics
- Veterinary Hospitals
- Veterinary Research Institutes
The regional markets for autogenous vaccine include:
- North America
- Asia Pacific
- Latin America
- Middle East and Africa
Regionally, North America and Europe are some of the leading regional autogenous vaccine markets. The growth of the regional markets is being driven by an increase in public and private funded initiatives for control and eradication of zoonotic diseases, such as the European Animal Health Strategy Programmes. Further, in developing regions, the rising incidences of the outbreak of rare contagious diseases have propelled the respective governments towards the increased immunisation of animals, thus, further catalysing the autogenous vaccine market. Additionally, the increase in research and development in these regions is likely to push the market growth further.
Key Market Players
The major players in the market are Newport Laboratories Inc, Elanco Animal Health Inc, Cambridge Technologies, Hygieia Biological Laboratories, AniCon Labor GmbH, and others. The report covers the market shares, capacities, plant turnarounds, expansions, investments and mergers and acquisitions, among other latest developments of these market players.
Expert Market Research (EMR) is leading market research company with clients across the globe. Through comprehensive data collection and skilful analysis and interpretation of data, the company offers its clients extensive, latest, and actionable market intelligence which enables them to make informed and intelligent decisions and strengthen their position in the market. The clientele ranges from Fortune 1000 companies to small and medium scale enterprises.
EMR customises syndicated reports according to clients’ requirements and expectations. The company is active across over 15 prominent industry domains, including food and beverages, chemicals and materials, technology and media, consumer goods, packaging, agriculture, and pharmaceuticals, among others.
Over 3000 EMR consultants and more than 100 analysts work very hard to ensure that clients get only the most updated, relevant, accurate and actionable industry intelligence so that they may formulate informed, effective and intelligent business strategies and ensure their leadership in the market.